Decreased protein levels and enzymatic activity of glucocerebrosidase were reported in the cerebrospinal fluid of patients with Parkinson’s disease independently of their GBA mutation carrier status [82–84], although such decrease was not significant in all studies [85]. Here, GBA1 is linked to Parkinson disease.